Skip to main content

WASATCH ADVISORS LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 814133 SALT LAKE CITY, UT

Position in ESPR

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$6,099,384
+$6,099,384 QoQ
Shares Held
1,930,185
-87.8% QoQ
Ownership
0.750%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2
of 40 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WASATCH ADVISORS LP holds $35,462,974 across 4 Drug Manufacturers - Specialty & Generic names. ESPR ranks #2 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ESPR
Esperion Therapeutics, Inc.
This page
1,930,185 $6,099,384

All Filings in ESPR

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,099,384 1,930,185
2026-06-30 $6,099,384 1,930,185
2026-03-31 15,768,897
2025-12-31 9,445,759
2025-09-30 7,061,857
2025-06-30 10,340,261
2025-03-31 10,931,257
2024-12-31 24,482,258
2024-09-30 23,346,013
2024-06-30 16,862,943
2024-03-31 9,129,647
2023-12-31 8,891,103
2023-09-30 11,526,100
2023-06-30 13,139,556
2023-03-31 13,354,186
2022-12-31 6,848,378
2022-09-30 7,463,016
2022-06-30 7,546,008
2022-03-31 8,147,380
2021-12-31 6,386,263
2021-09-30 3,274,360
2021-06-30 3,766,935
2021-03-31 4,118,085
2020-12-31 3,998,010
2020-09-30 2,409,683
2020-06-30 1,244,426
2020-03-31 906,336